V. Narry Kim
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)(Learn how and when to remove this template message)
|V. Narry Kim|
|Born||1969 (age 47–48)
|Residence||Seoul, South Korea|
|Fields||Biochemistry, Molecular Biology|
|Institutions||Institute for Basic Science/Seoul National University|
|Alma mater||Oxford University|
|Doctoral advisor||Alan J. Kingsman|
|Notable awards||S-Oil Leading Scientist of the Year (2013)
The Korea S&T Award (2013)
Amore Pacific the Grand Prize (2010)
Ho-Am Prize in Medicine (2009)
L'Oreal-UNESCO Women in Science Award (2008)
Woman Scientist of the Year (2007)
Thomson Scientific Citation Laureate Award (2007)
|V. Narry Kim|
|Revised Romanization||Gim Binnaeri|
Dr. V. Narry Kim is a South Korean biochemist and microbiologist, best known for her work on microRNA biogenesis. Her pioneering studies have laid the groundwork for the biology of microRNA and contributed to the improvement of RNA interference technologies.
Dr. V Narry Kim was born in Seoul Korea in 1969. Kim first became interested in science as a high school student. When asked why she chose science as a lifelong career, she said, “I was charmed by the simplicity of the principles underlying the complexity of life.” Kim went on to purse a bachelor of science degree, then followed by a master of science degree in 1992 and 1994 respectively, both from Seoul National University (SNU). SNU is considered one of the top universities in Asia. After completing her masters, Kim went to the United Kingdom to further her studies at the University of Oxford. She graduated with a PhD in philosophy in 1998. Her academic journey then took her to the United States, where she took a position at the Howard Hughes Medical Institute at the University of Pennsylvania in Philadelphia as research assistant. Kim finished her postdoctoral studies and returned to Korea in 2001. She then started working at SNU as a research assistant professor. By the age of 35, Dr. Kim already had twenty-two of her papers published in well known and prestigious scientific publications such as Science and Nature. In addition, Kim “holds four patents based on her research activities, including one on a novel HIV-based gene delivery vector.”
Dr. Kim received her doctoral degree from the University of Oxford where she studied the functions of retroviral proteins. After completing her postdoctoral research on mRNA surveillance in the laboratory of Gideon Dreyfuss at the University of Pennsylvania, she returned to Seoul National University in 2001 to set up her own lab.
Dr. Kim’s lab, funded by the Institute of Basic Science and Seoul National University, is focused on researches on RNA-mediated gene regulation. Specifically investigating post-transcriptional gene regulation mediated by microRNAs (miRNAs). The lab employs biochemistry, molecular biology, genetic, biophysical, and computational approaches. Research is focused on miRNAs, which are small non-coding RNAs involved in practically all working aspects of eukaryotic cells. Tight control of miRNA is vital to normal functioning cells. If dysregulated, miRNAs can often be linked to human diseases such as cancer. By focusing on the miRNA biogenesis, Dr. Kim’s lab has made major contributions to the understanding of miRNAs are created and processed in animal cells. These studies can potentially open the doors to new forms of cancer treatment and stem cell engineering.
In 2013, Dr. V. Narry KIM along with Professor Jin-Soo KIM of the SNU Department of Chemistry developed a new technology to eliminate specific microRNAs. This new technology has the promise of being potentially used to cure cancer and other illnesses in the future. In the research, TALENs (enzymes) were used to separate certain microRNA from a cell. TALENs had been used to create protein before, but this was the first time they have been used to separate microRNA. The team developed 540 different TALENs for this specific purpose. When this was applied to cancer cells, the proliferation rate of cancer cells dropped to one third of what it was. This discovery was published in the November 11, 2013 edition of Nature Structural and Molecular Biology.
Dr. Kim's first paper as PI was published in 2002 in the EMBO Journal. In this highly cited work, she defined two separate processing steps (primary microRNA (pri-miRNA) processing in the nucleus and pre-miRNA processing in the cytoplasm), and proposed a model of the microRNA biogenesis pathway for the first time. Based on this model, her research group discovered that most microRNA genes are transcribed by RNA polymerase II and that pri-miRNA processing is carried out by Drosha-DGCR8 complexes in the nucleus.
Her research group further identified uridylation-meditated pre-miRNA degradation pathway by LIN28 and TUT4, contributing to a better understanding of how microRNA-mediated gene expression regulation is involved in embryonic stem cell maintenance and cancer cell development. She also discovered the molecular basis for pri-miRNA recognition and cleavage by the Drosha-DGCR8 complexes, and pre-miRNA processing by Dicer. These findings suggested several critical points to be considered for designing more efficient short hairpin RNA (shRNA) vectors and also contributed to the improvement of RNA interference technologies.
In recognition of her contribution, Dr. V. Narry Kim received L'Oreal-UNESCO Award for Women in Science (2008), Ho-Am Prize in Medicine (2009) and The Korea S&T Award (2013). She is an active member of the RNA Society and the International Society of Stem Cell Research (ISSCR). In addition she has been recognized as one of the top Asian scientist to watch by Asian Scientist
||This section contains embedded lists that may be better presented using prose. (June 2012) (Learn how and when to remove this template message)|
- 1994–1998: Ph.D., Biochemistry, Oxford University (with Alan J. Kingsman)
- 1992–1994: M.S., Microbiology, Seoul National University (with Kang Sa-Ouk)
- 1988–1992: B.A., Microbiology, Seoul National University
- 2013–present: Professor, Seoul National University
- 2012–present: Director, Center for RNA Research, Institute for Basic Science
- 2010–present: SNU Distinguished Fellow, Seoul National University
- 2008–2013: Associate Professor, Seoul National University
- 2004–2008: Assistant Professor, Seoul National University
- 2001–2004: Research Assistant Professor, Seoul National University
- 1999–2001: Postdoctoral fellow, Howard Hughes Medical Institute, University of Pennsylvania (with Gideon Dreyfuss)
- 2015–present: Board of Reviewing Editors, Science
- 2014–present: Foreign Associate, National Academy of Sciences (NAS)
- 2014–present: Editorial Board, Molecular Cell
- 2012–present: Member, The Korean Academy of Science Technology
- 2014: Organizer, Keystone Symposia
- 2013–2014: Council Member, Presidential Advisory Council on Science and Technology
- 2013–2014: Meetings Committee, The RNA Society
- 2013–present: Foreign Associate, European Molecular Biology Organization (EMBO)
- 2012–present: Editorial Board, Genes & Development
- 2011-2012: Director, The RNA Society
- 2011: Co-organizer, ISSCR-Cold Spring Harbor Asia Joint Meeting, Suzhou, China
- 2011–present: Editorial Board, EMBO Journal
- 2011: Co-organizer, Keystone Symposia (RNA Silencing), Monterey, United States
- 2010–present: Editorial Board, Cell
- 2010–present: Member, Human Frontier Science Program Fellowship Review Committee
- 2010–2011: Director, The RNA Society
- 2009–present: Editorial Board, CellResearch
- 2009: Organizer, The 14th Annual Meeting of the RNA Society Meeting, Madison, United States
- 2008: Organizer, Seoul RNA Symposium, Seoul, South Korea
- 2007: Session Organizer and Publication Committee Member, FAOMB, Seoul, South Korea
- 2006–2008: Council Member, Presidential Advisory Council on Science and Technology, South Korea
- 2013: S-Oil Leading Scientist of the Year (S-Oil Science Prodigy and Culture Foundation, Korea)
- 2013: The Korea S&T Award (The Korean Federation of Science and Technology Societies, Korea) 
- 2013: Gwanak Grand Prize Honor Sector (Seoul National University, Korea)
- 2010: National Honor Scientist (Ministry of Education, Science and Technology, Korea)
- 2010: Amore Pacific the Grand Prize (Amore Pacific and KOFWST, Korea)
- 2009: Ho-Am Prize in Medicine (Ho-Am Foundation, Korea)
- 2008: L'Oréal-UNESCO Awards for Women in Science (L'Oreal and UNESCO)
- 2007: Woman Scientist of the Year (Ministry of Science and Technology, Korea)
- 2007: Young Scientist Award (Ministry of Science and Technology, Korea)
- 2007: Thomson Scientific Citation Award (Thomson Corporation)
- 2006: Research Award (Seoul National University, Korea)
Publications (Most representative 10 items)
- Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Rådmark O., Kim S., and Kim V.N. 2003.
The Nuclear RNase III Drosha Initiates MicroRNA Processing. Nature 425:415-419.
- Han J., Lee Y., Yeom K.H., Nam J., Lee K., Sohn S., Cho Y., Zhang B., and Kim V.N. 2006.
Molecular Basis for Primary MicroRNA Processing by the Drosha-DGCR8 complex. Cell 125:887-901.
- Heo I., Joo C, Cho J., Ha M., Han J. and Kim V.N. 2008.
Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Molecular Cell 32:276-284.
- Hyun S., Lee J. H., Jin H., Nam J.W., Namkoong B., Lee G., Chun J., and Kim V.N. 2009.
Conserved microRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell 139:1096-1108.
- Park J.E., Heo I., Y. Tian, D. K. Simanshu, Chang H., D. Jee, D. J. Patel and Kim V.N. 2011.
Dicer recognizes the 5’ end of RNA for efficient and accurate processing. Nature 475:201-205.
- Heo I., Ha M., Lim J., Yoon M., Park J.-E., Kwon S. C., Chang H., and Kim V. N. 2012.
Monouridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs. Cell 151: 521-532.
- Cho J., Chang H., Kwon S. C., Kim B., Kim Y., Choe J., Ha M., Kim Y. K., and Kim V. N. 2012.
LIN28A is a suppressor of ER-associated translation in embryonic stem cells. Cell 151: 765-777.
- Lim J., Ha M., Chang H., Kwon S. C., Simanshu D. K., Patel D.J., and Kim V. N. 2014.
Uridylation by TUT4 and TUT7 marks mRNA for degradation. Cell 159(6): 1365-1376.
- Nguyen T.A., Jo M. H., Choi Y.-G., Park J., Kwon S. C., Hohng S., Kim V. N.*, and Woo J.-S.* 2015.
Functional anatomy of the human Microprocessor. Cell 161(6): 1374-1387. (*co-corresponding authors)
- Cho J., Yu N.-K., Choi J.-H., Sim S.-E., Kang S. J., Kwak C., Lee S.-W., Kim J., Choi D. I., Kim V. N.*, and Kaang B.-K.* 2015.
Multiple repressive mechanisms in the hippocampus during memory formation. Science 350(6256): 82-87. (*co-corresponding authors)
- Lee Y, Jeon K, Lee JT, Kim S, Kim VN (September 2002). "MicroRNA maturation: stepwise processing and subcellular localization". EMBO J. 21 (17): 4663–4670. doi:10.1093/emboj/cdf476. PMC . PMID 12198168.
- Heo I, Joo C, Cho J, Ha M, Han J, Kim VN (October 2008). "Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA". Mol. Cell. 32 (2): 276–284. doi:10.1016/j.molcel.2008.09.014. PMID 18951094.
- Heo I, Joo C, Kim YK, Ha M, Yoon MJ, Cho J, Yeom KH, Han J, Kim VN (August 2009). "TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation". Cell. 138 (4): 696–708. doi:10.1016/j.cell.2009.08.002. PMID 19703396.
- Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, Sohn SY, Cho Y, Zhang BT, Kim VN (June 2006). "Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex". Cell. 125 (5): 887–901. doi:10.1016/j.cell.2006.03.043. PMID 16751099.
- Park JE, Heo I, Tian Y, Simanshu DK, Chang H, Jee D, Patel DJ, Kim VN (July 2011). "Dicer recognizes the 5' end of RNA for efficient and accurate processing". Nature. 475 (7355): 201–205. doi:10.1038/nature10198. PMID 21753850.
- "Tenth anniversary of the L'ORÉAL-UNESCO Awards For Women in Science". UNESCO. Retrieved 2012-01-14.
- "The Ho-Am Prize Laureates". Ho-Am Foundation. Retrieved 2012-01-14.